We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NESINA MET 12.5/500; 12.5 mg alogliptin (as benzoate) / 500 mg metformin hydrochloride film-coated tablets blister pack, Takeda Pharmaceuticals Australia Pty Ltd, CON-895
Product name
NESINA MET 12.5/500; 12.5 mg alogliptin (as benzoate) / 500 mg metformin hydrochloride film-coated tablets blister pack
Sponsor name
Takeda Pharmaceuticals Australia Pty Ltd
Batches
11996446
Consent start
Consent no.
CON-895
Duration
The consent is effective for the aforementioned batches only from 16 December 2021 until 31 January 2024.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The products do not conform with the requirements of paragraph 8(1)(i) of
Therapeutic Goods Order No. 91 – Standard for labels of prescription and related
medicines (TGO 91) in that the products do not include the current address of
the sponsor.
Import, Supply, &/or Export
Supply
Therapeutic product type
Prescription medicines